A detailed history of Arizona State Retirement System transactions in Amgen Inc stock. As of the latest transaction made, Arizona State Retirement System holds 153,705 shares of AMGN stock, worth $45.3 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
153,705
Previous 155,366 1.07%
Holding current value
$45.3 Million
Previous $48.5 Million 2.02%
% of portfolio
0.32%
Previous 0.33%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $513,880 - $560,388
-1,661 Reduced 1.07%
153,705 $49.5 Million
Q2 2024

Aug 05, 2024

BUY
$262.75 - $319.31 $469,534 - $570,606
1,787 Added 1.16%
155,366 $48.5 Million
Q1 2024

May 07, 2024

BUY
$268.87 - $324.56 $830,270 - $1 Million
3,088 Added 2.05%
153,579 $43.7 Million
Q4 2023

Jan 24, 2024

SELL
$255.7 - $288.46 $192,030 - $216,633
-751 Reduced 0.5%
150,491 $43.3 Million
Q3 2023

Nov 06, 2023

SELL
$218.65 - $271.46 $319,447 - $396,603
-1,461 Reduced 0.96%
151,242 $40.6 Million
Q2 2023

Aug 01, 2023

BUY
$214.27 - $253.37 $1.5 Million - $1.78 Million
7,013 Added 4.81%
152,703 $33.9 Million
Q1 2023

Apr 27, 2023

SELL
$225.79 - $275.2 $14,450 - $17,612
-64 Reduced 0.04%
145,690 $35.2 Million
Q4 2022

Feb 07, 2023

BUY
$229.03 - $291.01 $124,821 - $158,600
545 Added 0.38%
145,754 $38.3 Million
Q3 2022

Nov 07, 2022

SELL
$224.46 - $253.15 $1.71 Million - $1.93 Million
-7,610 Reduced 4.98%
145,209 $32.7 Million
Q2 2022

Jul 28, 2022

SELL
$230.71 - $256.74 $401,666 - $446,984
-1,741 Reduced 1.13%
152,819 $37.2 Million
Q1 2022

May 04, 2022

SELL
$219.27 - $242.57 $211,376 - $233,837
-964 Reduced 0.62%
154,560 $37.4 Million
Q4 2021

Feb 04, 2022

SELL
$198.88 - $227.6 $934,139 - $1.07 Million
-4,697 Reduced 2.93%
155,524 $35 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $339,419 - $397,671
-1,599 Reduced 0.99%
160,221 $34.1 Million
Q2 2021

Aug 02, 2021

SELL
$233.58 - $259.14 $522,518 - $579,696
-2,237 Reduced 1.36%
161,820 $39.4 Million
Q1 2021

May 06, 2021

SELL
$221.91 - $258.6 $1.09 Million - $1.28 Million
-4,932 Reduced 2.92%
164,057 $40.8 Million
Q4 2020

Jan 28, 2021

SELL
$216.38 - $257.67 $2.14 Million - $2.55 Million
-9,909 Reduced 5.54%
168,989 $38.9 Million
Q3 2020

Nov 05, 2020

BUY
$234.65 - $260.95 $9.47 Million - $10.5 Million
40,348 Added 29.12%
178,898 $45.5 Million
Q2 2020

Aug 04, 2020

BUY
$197.81 - $242.74 $6.27 Million - $7.7 Million
31,716 Added 29.69%
138,550 $32.7 Million
Q1 2020

May 05, 2020

SELL
$182.24 - $241.7 $863,453 - $1.15 Million
-4,738 Reduced 4.25%
106,834 $21.7 Million
Q4 2019

Jan 27, 2020

SELL
$189.21 - $243.2 $77,008 - $98,982
-407 Reduced 0.36%
111,572 $26.9 Million
Q3 2019

Oct 31, 2019

SELL
$174.11 - $208.62 $700,966 - $839,904
-4,026 Reduced 3.47%
111,979 $21.7 Million
Q2 2019

Jul 25, 2019

SELL
$166.7 - $195.41 $580,616 - $680,613
-3,483 Reduced 2.91%
116,005 $21.4 Million
Q1 2019

Apr 29, 2019

SELL
$180.87 - $203.88 $2.07 Million - $2.33 Million
-11,438 Reduced 8.74%
119,488 $22.7 Million
Q4 2018

Jan 28, 2019

SELL
$178.4 - $208.25 $5.26 Million - $6.14 Million
-29,503 Reduced 18.39%
130,926 $25.5 Million
Q3 2018

Oct 29, 2018

SELL
$185.29 - $208.89 $592,742 - $668,239
-3,199 Reduced 1.96%
160,429 $33.3 Million
Q2 2018

Aug 07, 2018

SELL
$166.05 - $186.51 $1.69 Million - $1.9 Million
-10,190 Reduced 5.86%
163,628 $30.2 Million
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $3.54 Million - $4.14 Million
-20,900 Reduced 10.73%
173,818 $29.6 Million
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $2.34 Million - $2.61 Million
13,836 Added 7.65%
194,718 $33.9 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $30.3 Million - $34.5 Million
180,882
180,882 $33.7 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.